Form 483

Chartwell Pharmaceuticals Congers, LLC Form 483, 2024-04-08

FDA issued a Form 483 to Chartwell Pharmaceuticals Congers, LLC on 2024-04-08 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Chartwell Pharmaceuticals Congers, LLC · Congers, United States · Issued April 8, 2024

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

8 Apr 2024
21 CFR 314.80(c)(2)

Interval

Cited by Asia D Clark

8 Apr 2024
21 CFR 314.80(c)(2)

Late submission of annual safety reports

Cited by Asia D Clark

8 Apr 2024
21 CFR 314.80(c)(2)

Late submission of quarterly safety reports

Cited by Asia D Clark

8 Apr 2024
21 CFR 314.81(b)(2)

Timely submission

Cited by Asia D Clark

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 314.80(c)(2)Cited across public-safe Form 483 observations3x
21 CFR 314.81(b)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere